No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

David Marlin is the President and Co-Founder of MetaComet® Systems, a prominent provider of royalty automation tools. Since founding the company in 2000, David has spearheaded the development of a suite of best-in-class systems that effectively facilitate royalty processes for nearly 200 publishers. David has also served as the chair for The Book Industry Study Group’s Rights Committee and Digital Sales Committee.
Before establishing MetaComet Systems, David served as a technology consultant for renowned publishers, collaborating with notable companies such as Random House, Penguin, HarperCollins, Holtzbrinck, Macmillan, Scholastic, Time Warner, and many others. David holds both an MBA and a BA from Columbia University in New York.
If your business has acquired the rights to use another party’s invention, creation, or intellectual property (IP), then congratulations: you are now a licensee! Licensees pay licensing royalties to a licensor when they monetize the IP they have acquired.
Explore how copyright royalties work, plus types and examples, and discover automation tools that prevent errors.
Choosing a rights management system can feel overwhelming at first, but it doesn’t have to be that way. In this FAQ, you’ll learn exactly how to select and implement a solution that truly fits your workflow and empowers you to maximize all your licensing opportunities and revenue.
The new world of multi-format distribution adds enormous complexity to royalty math. That’s where tools like MetaComet’s best-in-class royalty management solutions come in.
When something is sold on a royalty basis, its license holders calculate and put aside a share of the earnings to compensate the original creators. That money is then distributed to recipients in an agreed manner and on a set cycle.
Learn how biotech licensees manage technology transfer agreements, track royalties, and stay compliant through every stage of the licensing process.
If you’re involved in licensing technology from a university, research institution, or federal lab—or granting those rights to others—managing royalties is one of the most critical (and complex) parts of the process.
Not all software is created equal. For the large majority of royalty-based businesses, specialist solutions will beat generalist products on every count. Here are just ten reasons why.
Learn what royalty rates are, how they’re calculated, what affects them, and what to expect in a licensing agreement in this practical guide.
Revenue sharing gives licensees a cut of revenue based on use or sales, aligning payouts with performance and encouraging long-term success.
"*" indicates required fields